Oberotatug Ravtansine

Approval Year

Name

Type

Language

Oberotatug Ravtansine

Official Name

English

oberotatug ravtansine [INN]

Common Name

English

Gamma1 heavy chain Homo sapiens (1-448) [VH (Homo sapiens IGHV3-15*01 (98.0%) -(IGHD) -IGHJ4*01 (100%), CDR-IMGT [8.10.10] (26-33.51-60.99-108)) (1-119) -Homo sapiens IGHG1*03v, G1m3>G1m17, nG1m1 CH1 K120, CH3 E12, M14( CH1 R120>K (216) (120-217), hinge

Common Name

English

Immunoglobulin G1-kappa, anti-[Homo sapiens LY75 (human lymphocyte antigen 75, C-type lectin domain family 13 member B, CLEC13B, DEC-205, CD205)], Homo sapiens monoclonal antibody; conjugated to maytansinoid DM4

Common Name

English

Code System Code Type Description

FDA UNII

N2Q7V645PL

Created by admin on Sat Dec 16 14:45:48 GMT 2023 , Edited by admin on Sat Dec 16 14:45:48 GMT 2023

PRIMARY

NCI_THESAURUS

C199080

Created by admin on Sat Dec 16 14:45:48 GMT 2023 , Edited by admin on Sat Dec 16 14:45:48 GMT 2023

PRIMARY

CAS

2641919-35-7

Created by admin on Sat Dec 16 14:45:48 GMT 2023 , Edited by admin on Sat Dec 16 14:45:48 GMT 2023

PRIMARY

INN

12296

Created by admin on Sat Dec 16 14:45:48 GMT 2023 , Edited by admin on Sat Dec 16 14:45:48 GMT 2023

PRIMARY

ACTIVE MOIETY


					N2Q7V645PL

Oberotatug Ravtansine